RBP4 and peripheral arterial disease: Especially, emerging evidence have also revealed the association between adipokines and the development of lower extremity PAD as altered serum level of adipokines might act as independent risk factors, for instance, reduced adiponectin [24], reduced omentin-1 [25], and elevated retinol binding protein 4 (RBP4) [26].